Report Provides Insight into the Pipeline Status of Depression Drugs By Company and By Stage
Posted on: Thursday, 13 September 2007, 06:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c68266) has announced the addition of "Central Nervous System - Depression Drug Pipeline Report" to their offering.
"Central Nervous System - Depression Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of depression drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
Keep track of your competitors and partners by better understanding their product pipeline.
Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
Maintain a critical competitive advantage.
RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes UPCOMING PATENT EXPIRES BY THERAPY AREA Depression Pipeline Overview --% of Projects (By Phase of Development) --No. of Projects by Phase of Development --Marketed Products Vs. Pipeline Products Company Overview - Pipeline Projects --Company Overview - Pipeline Projects --Legend --Top 20 companies in late stage Depression Projects --Top 20 companies in early stage Depression Projects Full Pipeline View --Phase I Pipeline View --Phase II Pipeline View --Pending Approval Pipeline View --Approved Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c68266
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Energy, Refining and Pipeline Construction Projects Push Wisconsin Industrial Development to $14.6 Billion, an Industrial Info News Alert
- Heartland Oil and Gas Continues Production Enhancement and Well and Pipeline Expansion Projects in Texas and Kansas
- GO Networks Wins Product Acceptance By U.S. Govt. Rural Development Telecommunications Program
- IBC Expands Coverage of Case Studies and Projects in Preclinical, Phase 1 and Phase 2
- BP Launches Open Season on Proposed Pipeline Reversal Project to Bring Light Canadian Crude to Cushing
- Energy Transfer Partners, L.P. Continues Timely Completion of 42-Inch Pipeline Construction Project
- Energy Transfer Partners, L.P. Announces Completion of First Phase of 42-Inch Pipeline Expansion Project
- Tranzyme's First Product Shows Safety in Phase I Study
- Indiana Health Information Exchange Selected to Participate in First Phase Development of RHIO Best Practices
- Pro-Pharmaceuticals Completes Patient Enrollment in Stage 1 of Phase II Colorectal Cancer Trial Evaluating DAVANAT(R) With 5-FU
 |
 |
User Comments (0)
RSS Feeds